Osteoinductive bone graft substitutes for lumbar fusion: A systematic review - Clinical article

Journal of Neurosurgery: Spine

Volumn 11, Issue 6, 2009, Pages 729-740

  Agarwal, Rajender ^a   Williams, Kendal ^a,b   Umscheid, Craig A ^a,b   Welch, William C ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bone morphogenetic protein; Bone substitute; Lumbar fusion; Meta analysis; Systematic review

Indexed keywords

CALCIUM PHOSPHATE; CARBOXYMETHYLCELLULOSE; COLLAGEN; COLLAGEN SPONGE; HYDROXYAPATITE; OSTEOGENIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT BONE MORPHOGENETIC PROTEIN 3; RECOMBINANT OSTEOGENIC PROTEIN 1; UNCLASSIFIED DRUG;

ALLOGRAFT; ARTICLE; AUTOGRAFT; BLEEDING; BONE DEMINERALIZATION; BONE GRAFT; BONE MATRIX; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; DISABILITY; EMBASE; FRACTURE NONUNION; HOSPITALIZATION; HUMAN; ILIAC CREST; LAMINECTOMY; LENGTH OF STAY; MEDLINE; META ANALYSIS; OPERATION DURATION; PEDICLE SCREW; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK FACTOR; SPINE FUSION; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW;

BONE MORPHOGENETIC PROTEINS; BONE SUBSTITUTES; HUMANS; LUMBAR VERTEBRAE; OSTEOGENESIS; SPINAL FUSION;

EID: 73249116149     PISSN: 15475654     EISSN: 15475646     Source Type: Journal    
DOI: 10.3171/2009.6.SPINE08669     Document Type: Article

References (47)

1. Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101, 1994
2. Boden SD: Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine 27: S26-S31, 2002
3. Boden SD, Kang J, Sandhu H, Heller JG: Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective, randomized clinical pilot trial: 2002 Volvo award in clinical studies. Spine (Phila Pa 1976) 27:2662-2673, 2002
4. Boden SD, Zdeblick TA, Sandhu HS, Heim SE: The use of rhBMP-2 in interbody fusion cages. definitive evidence of osteoinduction in humans: A preliminary report. Spine 25:376-381, 2000
5. Burkus JK, Dorchak JD, Sanders DL: Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2. Spine 28:372-377, 2003
6. Burkus JK, Gornet MF, Dickman CA, Zdeblick TA: Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 15:337-349, 2002
7. Burkus JK, Sandhu HS, Gornet MF, Longley MC: Use of rhBMP-2 in combination with structural cortical allografts: Clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am 87:1205-1212, 2005
8. Burkus JK, Transfeldt EE, Kitchel SH, Watkins RG, Balderston RA: Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 27:2396-2408, 2002
9. Cammisa FP Jr, Lowery G, Garfin SR, Geisler FH, Klara PM, McGuire RA, et al: Two-year fusion rate equivalency between grafton DBM gel and autograft in posterolateral spine fusion: A prospective controlled trial employing a side-byside comparison in the same patient. Spine (Phila Pa 1976) 29:660-666, 2004
10. Carreon LY, Glassman SD, Anekstein Y, Puno RM: Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusions. Spine 30:E243-E246, 2005
11. Carreon LY, Glassman SD, Brock DC, Dimar JR, Puno RM, Campbell MJ: Adverse events in patients re-exposed to bone morphogenetic protein for spine surgery. Spine 33:391-393, 2008
12. Castro FP Jr: Role of activated growth factors in lumbar spinal fusions. J Spinal Disord Tech 17:380-384, 2004
13. Collins R, Gray R, Godwin J, Peto R: Avoidance of large biases and large random errors in the assessment of moderate treatment effects: The need for systematic overviews. Stat Med 6:245-254, 1987
14. Deyo RA, Nachemson A, Mirza SK: Spinal-fusion surgery-the case for restraint. N Engl J Med 350:722-726, 2004
15. Dimar JR, Glassman SD, Burkus KJ, Carreon LY: Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 31:2534-2539, 2006
16. Duval S, Tweedie R: Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in metaanalysis. Biometrics 56:455-463, 2000
17. Egger M, Smith GD: Bias in location and selection of studies. BMJ 316:61-66, 1998
18. Egger M, Smith GD, Altman DG: Systematic Reviews in Health Care: Meta-Analysis in Context, ed 2. London: BMJ Publishing Group, 2001
19. Fairbank JC, Couper J, Davies JB, O'Brien JP: The oswestry low back pain disability questionnaire. Physiotherapy 66:271-273, 1980
20. Garrison KR, Donell S, Ryder J, Shemilt I, Mugford M, Harvey I, et al: Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: A systematic review. Health Technol Assess 11:1-150, 2007
21. Glassman SD, Carreon LY, Campbell MJ, Johnson JR, Puno RM, Djurasovic M, et al: The perioperative cost of infuse bone graft in posterolateral lumbar spine fusion. Spine J 8:443-448, 2008
22. Glassman SD, Dimar JR, Carreon LY, Campbell MJ, Puno RM, Johnson JR: Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion. Spine 30:1694-1698, 2005
23. Haid RW Jr, Branch CL Jr, Alexander JT, Burkus JK: Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 4:527-539, 2004
24. Hidaka C, Cunningham ME, Rodeo SA, Maher SA, Zhu W: Modern biologics used in orthopaedic surgery. Curr Opin Rheumatol 18:74-79, 2006
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 327:557-560, 2003
26. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1-12, 1996
27. Jenis LG, Banco RJ, Kwon B: A prospective study of autologous growth factors (AGF) in lumbar interbody fusion. Spine J 6:14-20, 2006
28. Johnsson R, Stromqvist B, Aspenberg P: Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo award in clinical studies. Spine 27:2654-2661, 2002
29. Kanayama M, Hashimoto T, Shigenobu K, Yamane S, Bauer TW, Togawa D: A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: Emphasis of surgical exploration and histologic assessment. Spine 31:1067-1074, 2006
30. Lane JM: Bone morphogenic protein science and studies. J Orthop Trauma 19:S17-S22, 2005
31. Mussano F, Ciccone G, Ceccarelli M, Baldi I, Bassi F: Bone morphogenetic proteins and bone defects: A systematic review. Spine 32:824-830, 2007
32. Polly DW Jr, Ackerman SJ, Shaffrey CI, Ogilvie JW, Wang JC, Stralka SW, et al: A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. Orthopedics 26:1027-1037, 2003
33. Pradhan BB, Bae HW, Dawson EG, Patel VV, Delamarter RB: Graft resorption with the use of bone morphogenetic protein: Lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2. Spine 31:E277-E284, 2006
34. Resnick DK: Evidence-based spine surgery. Spine 32:S15-S19, 2007
35. Resnick DK, Choudhri TF, Dailey AT, Groff MW, Khoo L, Matz PG, et al: Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: Bone graft extenders and substitutes. J Neurosurg Spine 2:733-736, 2005
36. Samartzis D, Khanna N, Shen FH, An HS: Update on bone morphogenetic proteins and their application in spine surgery. J Am Coll Surg 200:236-248, 2005
37. Sassard WR, Eidman DK, Gray PM, Block JE, Russo R, Russell JL, et al: Augmenting local bone with grafton demineralized bone matrix for posterolateral lumbar spine fusion: Avoiding second site autologous bone harvest. Orthopedics 23:1059-1064, 2000
38. Singh K, Smucker JD, Boden SD: Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: A prospective CT-scan analysis at one and two years. J Spinal Disord Tech 19:416-423, 2006
39. Slosar PJ, Josey R, Reynolds J: Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. Spine J 7:301-307, 2007
40. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR: Empirical assessment of effect of publication bias on metaanalyses. BMJ 320:1574-1577, 2000
41. Vaccaro AR, Anderson DG, Patel T, Fischgrund J, Truumees E, Herkowitz HN, et al: Comparison of OP-1 putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: A minimum 2-year follow-up pilot study. Spine 30:2709-2716, 2005
42. Vaccaro AR, Patel T, Fischgrund J, Anderson DG, Truumees E, Herkowitz H, et al: A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 14:623-629, 2005
43. Vaccaro AR, Patel T, Fischgrund J, Anderson DG, Truumees E, Herkowitz H, et al: A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 12:495-500, 2003
44. Vaccaro AR, Patel T, Fischgrund J, Anderson DG, Truumees E, Herkowitz HN, et al: A pilot study evaluating the safety and efficacy of OP-1 putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 29:1885-1892, 2004
45. Vaccaro AR, Patel TC, Truumees E, Fischgrund JS, Herkowitz H, Albert T, et al: One year follow up on patients in a pilot safety and efficacy study of OP-1 (RHBMP-7) in posterolateral lumbar fusion as a replacement for iliac crest autograft. J Bone Joint Surg Br Proceedings 86B:89, 2004
46. Vaccaro AR, Stubbs HA, Block JE: Demineralized bone matrix composite grafting for posterolateral spinal fusion. Orthopedics 30:567-570, 2007
47. Vaccaro AR, Whang PG, Patel T, Phillips FM, Anderson DG, Albert TJ, et al: The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: Minimum 4-year follow-up of a pilot study. Spine J 8:457-465, 2008